Tower Research Capital LLC (TRC) - ALLOGENE THERAPEUTICS INC ownership

ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 3 filers reported holding ALLOGENE THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 2.3%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of ALLOGENE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$26,149
-61.4%
8,249
-39.5%
0.00%
-50.0%
Q2 2023$67,761
+161235.7%
13,634
+61.7%
0.00%
+100.0%
Q1 2023$42
-59.6%
8,434
-48.7%
0.00%
-75.0%
Q4 2022$104
-100.0%
16,454
-39.7%
0.00%
-20.0%
Q3 2022$295,000
+40.5%
27,278
+48.0%
0.01%0.0%
Q2 2022$210,000
-13.6%
18,427
-30.9%
0.01%
+150.0%
Q1 2022$243,000
+10.0%
26,665
+80.1%
0.00%
-50.0%
Q4 2021$221,000
-30.1%
14,806
+20.3%
0.00%
-50.0%
Q3 2021$316,000
+95.1%
12,307
+97.5%
0.01%
+100.0%
Q2 2021$162,000
-11.0%
6,230
+20.6%
0.00%
+33.3%
Q1 2021$182,000
+36.8%
5,165
-2.0%
0.00%
-25.0%
Q4 2020$133,000
+2.3%
5,272
+53.3%
0.00%
+300.0%
Q3 2020$130,000
-76.6%
3,439
-73.5%
0.00%
-95.7%
Q2 2020$556,000
+55500.0%
12,983
+20185.9%
0.02%
Q1 2020$1,000
-99.1%
64
-98.5%
0.00%
-100.0%
Q4 2019$110,000
+41.0%
4,216
+46.5%
0.01%
+80.0%
Q3 2019$78,000
+3800.0%
2,878
+3789.2%
0.01%
Q2 2019$2,000740.00%
Other shareholders
ALLOGENE THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
VV Manager LLC 1,798,163$76,997,00067.53%
Wildcat Capital Management, LLC 1,515,524$64,895,00022.42%
TPG Group Holdings (SBS) Advisors, Inc. 19,716,306$844,252,00014.91%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 1,279,281$54,779,0007.69%
Coastal Bridge Advisors, LLC 463,117$19,831,0006.33%
DSAM Partners (London) Ltd 235,098$10,067,0002.63%
Casdin Capital, LLC 625,000$26,763,0001.58%
Alpine Global Management, LLC 150,000$6,423,0001.13%
Perceptive Advisors 1,543,790$66,105,0001.07%
Avoro Capital Advisors LLC 1,128,594$48,326,0000.96%
View complete list of ALLOGENE THERAPEUTICS INC shareholders